Statecs

Statecs

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Statecs is a private, revenue-generating services company that provides a technology-enabled CRO model. Its core business is offering software solutions and services for managing clinical trials and ensuring regulatory compliance, leveraging digital health and AI tools to improve efficiency for pharmaceutical clients. Based in the key biopharma hub of Basel, the company is positioned to serve a global market. As a private entity, its financial details and specific leadership are not publicly disclosed, but its established presence since 2005 suggests a stable operational history.

Digital HealthAI / Machine Learning

Technology Platform

Develops software solutions integrating AI and machine learning for clinical trial management and regulatory compliance, likely including EDC, CTMS, and RIM systems.

Opportunities

The growing demand for digital transformation in clinical trials and increasing regulatory complexity create a large market for integrated software and service solutions.
Expansion into new geographic markets and therapeutic areas presents significant growth potential.

Risk Factors

Intense competition from large global CROs and agile tech startups poses a market share threat.
Reliance on the pharmaceutical R&D cycle and potential client concentration create revenue volatility risks.

Competitive Landscape

Statecs competes in the fragmented CRO and clinical trial software market against large players like IQVIA and Parexel, as well as pure-play software vendors like Veeva Systems and Medidata. Its differentiation lies in combining mid-sized CRO services with proprietary, AI-enhanced software platforms.